0

Close
 
2022
Cri-du-chat Syndrome Treatment Market

Cri-du-chat Syndrome Treatment Market

by Treatment (Physiotherapy, Speech therapy, Occupational therapy), by End User (Hospitals and specialty clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

LS : Pharmaceuticals
Report Code: A15445
Oct 2022 | Pages: 148
Tables: 113
Charts: 54

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

Cri-du-chat Syndrome Treatment Market Research, 2031

The global cri-du-chat syndrome treatment market was valued at $1.3 million in 2021, and is projected to reach $1.9 million by 2031, growing at a CAGR of 3.7% from 2022 to 2031. Cri-du-chat syndrome hampers growth and development and is evident at birth. Infants with this syndrome frequently have a high-pitched, feline-like scream, a small head, and distinctive facial features. Common signs include a peculiar cry that sounds like a cat meowing, distinctive facial traits, delayed growth, and microcephaly, which is characterized by a smaller head size than would be typical for an infant's age and sex.

People suffering from cri-du-chat syndrome confined themselves at home due to fear of getting infected by COVID. There was a decrease in physiotherapy, occupational and speech therapy visits in hospitals and clinics. Thus, the COVID-19 outbreak had a negative impact on the growth of the global cri-du-chat syndrome treatment market.

Cri-du-chat Syndrome Treatment Market

A small percentage of babies with the cri-du-chat syndrome are born with fatal consequences, including major organ problems (particularly heart or kidney defects). The majority of fatal problems happen before the child turns one. Some of the genes on Chromosome 5 are absent in children with the cri-du-chat syndrome, typically for unclear causes. Each child will experience this differently, but the majority of them will experience delayed development and some level of intellectual handicap.

In the last decade, there has been a significant increase in awareness among the population about physiotherapy. The increase in the prevalence of cri-du-chat syndrome and out-of-pocket healthcare expenditure has led to a significant rise in healthcare costs.All these factors are driving the the cri-du-chat syndrome treatment market growth. The rise in new services for physical therapy, such as pre-recorded video material and computer or video calls, further boosts the cri-du-chat syndrome treatment market opportunity.

According to the National Organization for Rare Diseases, more women suffer from cri-du-chat syndrome than men. 1 in15,000 to 50,000 children are born with cri-du-chat syndrome average per year. It can be challenging to estimate the true prevalence of cri-du-chat syndrome in the general community because some cases may go undetected.

Despite increased awareness, healthcare users are not fully aware of the effective employment of physiotherapy because it is still in its infancy. This increases the price of physiotherapy,which hinders the market growth. Conversely, the rising purchasing power ofpeople in emerging economies in the Asia-Pacific and LAMEA regions providesone of the highest growth potentials for the cri-du-chat syndrome treatment market. In addition, regulatory authorities in developing nations have taken significant steps to amend the laws governing cri-du-chat syndrome due to rise in awareness  of physiotherapy among people.
 

Impact of COVID-19
During the pandemic,due to the guidelines for maintaining social distancing, many patients managed the disease through self-medication or non-medically-approved strategies. During the lockdown,the slowdown of manufacturing, logistics, and transportation activities disruptedthe supply chain, which impeded market growth. People suffering from cri-du-chat syndrome confined themselves at home due to fear of getting infected by COVID. Thus, the COVID-19 outbreak had a negative impact on the growth of the global cri-du-chat syndrome treatment market share. However, vaccination drive is expected to bring stabilization to the cri-du-chat syndrome treatment market forecast.

Market Segmentation

The cri-du-chat syndrome treatment market is segmented on the basis of treatment, end user, and region. On the basis of product, the market is categorized into physiotherapy, speech therapy, and occupation therapy. On the basis of end user, it is segmented into hospitals & specialty clinics, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).

Segment Review
On the basis of treatment, the cri-du-chat syndrome treatment market size is segmented into physiotherapy, occupation therapy, and speech therapy. The physiotherapy segment generated maximum revenue in 2021 and is also expected to witness the highest CAGR during the forecast period, owing to the rise in awareness about physiotherapy and its advantages. 

Cri-du-chat Syndrome Treatment Market

On the basis of end user, the cri-du-chat syndrome treatment market size is divided into hospitals &specialty clinics and others. The hospitals &specialty clinics segment dominated the market in 2021,owing to the fact that hospitals provide higher capacity for both outpatients and inpatients. The others segment is expected to register the highest CAGR during the forecast period, owing to rise in demand for remote private care services.

Cri-du-chat Syndrome Treatment Market

North America accounted for a majority of the global cri-du-chat syndrome treatment market share in 2021 and is anticipated to remain dominant during the forecast period. This is attributed to technological advancements in physiotherapy techniques, rise in awareness about physiotherapy treatment for cri-du-chat syndrome, and presence of key and robust hospital infrastructure in the region. Asia-Pacific is anticipated to witness notable growth, owing to rise in prevalence of cri-du-chat syndrome, development of healthcare infrastructure, and increase in investments and projects in the region.

Cri-du-chat Syndrome Treatment Market

The major players profiled in the report of cri-du-chat syndrome treatment industry are Hoppers Physio, Jeevam Therapy, Physiocomestoyou, Euro-Therapies, the Institute for Child Development, Blossoms Physiotherapy, Pediatric Advanced Therapy, Chatham Speech and Myo, Movement Masters Physical Therapy, and Rio Children's Hospital.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cri-du-chat syndrome treatment market analysis from 2021 to 2031 to identify the prevailing cri-du-chat syndrome treatment industry opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the cri-du-chat syndrome treatment market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global cri-du-chat syndrome treatment market trends, key players, market segments, application areas, and market growth strategies.

 Cri-du-chat Syndrome Treatment Market Report Highlights

Aspects Details
Market Size By 2031 USD 1.9 million
Growth Rate CAGR of 3.7%
Forecast period 2021 - 2031
Report Pages 148
By Treatment
  • Physiotherapy
  • Speech therapy
  • Occupational therapy
By End User
  • Hospitals and specialty clinics
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players Rio Children's Hospital, Movement Masters Physical Therapy, Institute for Child Development, Hoppers Physio, Blossoms Physiotherapy, Physiocomestoyou, EURO-THERAPIES, Chatham Speech and Myo, Pediatric Advanced Therapy, Jeevam Therapy
 

  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Top player positioning

    • 3.5.Market dynamics

      • 3.5.1.Drivers

      • 3.5.2.Restraints

      • 3.5.3.Opportunities

    • 3.6.COVID-19 Impact Analysis on the market

  • CHAPTER 4: CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 Physiotherapy

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market share analysis by country

    • 4.3 Speech therapy

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market share analysis by country

    • 4.4 Occupational therapy

      • 4.4.1 Key market trends, growth factors and opportunities

      • 4.4.2 Market size and forecast, by region

      • 4.4.3 Market share analysis by country

  • CHAPTER 5: CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 Hospitals and specialty clinics

      • 5.2.1 Key market trends, growth factors and opportunities

      • 5.2.2 Market size and forecast, by region

      • 5.2.3 Market share analysis by country

    • 5.3 Others

      • 5.3.1 Key market trends, growth factors and opportunities

      • 5.3.2 Market size and forecast, by region

      • 5.3.3 Market share analysis by country

  • CHAPTER 6: CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY REGION

    • 6.1 Overview

      • 6.1.1 Market size and forecast

    • 6.2 North America

      • 6.2.1 Key trends and opportunities

      • 6.2.2 North America Market size and forecast, by Treatment

      • 6.2.3 North America Market size and forecast, by End User

      • 6.2.4 North America Market size and forecast, by country

        • 6.2.4.1 U.S.
          • 6.2.4.1.1 Key market trends, growth factors and opportunities
          • 6.2.4.1.2 Market size and forecast, by Treatment
          • 6.2.4.1.3 Market size and forecast, by End User
        • 6.2.4.2 Canada
          • 6.2.4.2.1 Key market trends, growth factors and opportunities
          • 6.2.4.2.2 Market size and forecast, by Treatment
          • 6.2.4.2.3 Market size and forecast, by End User
        • 6.2.4.3 Mexico
          • 6.2.4.3.1 Key market trends, growth factors and opportunities
          • 6.2.4.3.2 Market size and forecast, by Treatment
          • 6.2.4.3.3 Market size and forecast, by End User

    • 6.3 Europe

      • 6.3.1 Key trends and opportunities

      • 6.3.2 Europe Market size and forecast, by Treatment

      • 6.3.3 Europe Market size and forecast, by End User

      • 6.3.4 Europe Market size and forecast, by country

        • 6.3.4.1 Germany
          • 6.3.4.1.1 Key market trends, growth factors and opportunities
          • 6.3.4.1.2 Market size and forecast, by Treatment
          • 6.3.4.1.3 Market size and forecast, by End User
        • 6.3.4.2 France
          • 6.3.4.2.1 Key market trends, growth factors and opportunities
          • 6.3.4.2.2 Market size and forecast, by Treatment
          • 6.3.4.2.3 Market size and forecast, by End User
        • 6.3.4.3 UK
          • 6.3.4.3.1 Key market trends, growth factors and opportunities
          • 6.3.4.3.2 Market size and forecast, by Treatment
          • 6.3.4.3.3 Market size and forecast, by End User
        • 6.3.4.4 Italy
          • 6.3.4.4.1 Key market trends, growth factors and opportunities
          • 6.3.4.4.2 Market size and forecast, by Treatment
          • 6.3.4.4.3 Market size and forecast, by End User
        • 6.3.4.5 Spain
          • 6.3.4.5.1 Key market trends, growth factors and opportunities
          • 6.3.4.5.2 Market size and forecast, by Treatment
          • 6.3.4.5.3 Market size and forecast, by End User
        • 6.3.4.6 Rest of Europe
          • 6.3.4.6.1 Key market trends, growth factors and opportunities
          • 6.3.4.6.2 Market size and forecast, by Treatment
          • 6.3.4.6.3 Market size and forecast, by End User

    • 6.4 Asia-Pacific

      • 6.4.1 Key trends and opportunities

      • 6.4.2 Asia-Pacific Market size and forecast, by Treatment

      • 6.4.3 Asia-Pacific Market size and forecast, by End User

      • 6.4.4 Asia-Pacific Market size and forecast, by country

        • 6.4.4.1 Japan
          • 6.4.4.1.1 Key market trends, growth factors and opportunities
          • 6.4.4.1.2 Market size and forecast, by Treatment
          • 6.4.4.1.3 Market size and forecast, by End User
        • 6.4.4.2 China
          • 6.4.4.2.1 Key market trends, growth factors and opportunities
          • 6.4.4.2.2 Market size and forecast, by Treatment
          • 6.4.4.2.3 Market size and forecast, by End User
        • 6.4.4.3 India
          • 6.4.4.3.1 Key market trends, growth factors and opportunities
          • 6.4.4.3.2 Market size and forecast, by Treatment
          • 6.4.4.3.3 Market size and forecast, by End User
        • 6.4.4.4 Australia
          • 6.4.4.4.1 Key market trends, growth factors and opportunities
          • 6.4.4.4.2 Market size and forecast, by Treatment
          • 6.4.4.4.3 Market size and forecast, by End User
        • 6.4.4.5 South Korea
          • 6.4.4.5.1 Key market trends, growth factors and opportunities
          • 6.4.4.5.2 Market size and forecast, by Treatment
          • 6.4.4.5.3 Market size and forecast, by End User
        • 6.4.4.6 Rest of Asia-Pacific
          • 6.4.4.6.1 Key market trends, growth factors and opportunities
          • 6.4.4.6.2 Market size and forecast, by Treatment
          • 6.4.4.6.3 Market size and forecast, by End User

    • 6.5 LAMEA

      • 6.5.1 Key trends and opportunities

      • 6.5.2 LAMEA Market size and forecast, by Treatment

      • 6.5.3 LAMEA Market size and forecast, by End User

      • 6.5.4 LAMEA Market size and forecast, by country

        • 6.5.4.1 Brazil
          • 6.5.4.1.1 Key market trends, growth factors and opportunities
          • 6.5.4.1.2 Market size and forecast, by Treatment
          • 6.5.4.1.3 Market size and forecast, by End User
        • 6.5.4.2 Saudi Arabia
          • 6.5.4.2.1 Key market trends, growth factors and opportunities
          • 6.5.4.2.2 Market size and forecast, by Treatment
          • 6.5.4.2.3 Market size and forecast, by End User
        • 6.5.4.3 South Africa
          • 6.5.4.3.1 Key market trends, growth factors and opportunities
          • 6.5.4.3.2 Market size and forecast, by Treatment
          • 6.5.4.3.3 Market size and forecast, by End User
        • 6.5.4.4 Rest of LAMEA
          • 6.5.4.4.1 Key market trends, growth factors and opportunities
          • 6.5.4.4.2 Market size and forecast, by Treatment
          • 6.5.4.4.3 Market size and forecast, by End User

  • CHAPTER 7: COMPANY LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top winning strategies

    • 7.3. Product Mapping of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Key developments

  • CHAPTER 8: COMPANY PROFILES

    • 8.1 Hoppers Physio

      • 8.1.1 Company overview

      • 8.1.2 Company snapshot

      • 8.1.3 Operating business segments

      • 8.1.4 Product portfolio

      • 8.1.5 Business performance

      • 8.1.6 Key strategic moves and developments

    • 8.2 Jeevam Therapy

      • 8.2.1 Company overview

      • 8.2.2 Company snapshot

      • 8.2.3 Operating business segments

      • 8.2.4 Product portfolio

      • 8.2.5 Business performance

      • 8.2.6 Key strategic moves and developments

    • 8.3 Physiocomestoyou

      • 8.3.1 Company overview

      • 8.3.2 Company snapshot

      • 8.3.3 Operating business segments

      • 8.3.4 Product portfolio

      • 8.3.5 Business performance

      • 8.3.6 Key strategic moves and developments

    • 8.4 EURO-THERAPIES

      • 8.4.1 Company overview

      • 8.4.2 Company snapshot

      • 8.4.3 Operating business segments

      • 8.4.4 Product portfolio

      • 8.4.5 Business performance

      • 8.4.6 Key strategic moves and developments

    • 8.5 Institute for Child Development

      • 8.5.1 Company overview

      • 8.5.2 Company snapshot

      • 8.5.3 Operating business segments

      • 8.5.4 Product portfolio

      • 8.5.5 Business performance

      • 8.5.6 Key strategic moves and developments

    • 8.6 Blossoms Physiotherapy

      • 8.6.1 Company overview

      • 8.6.2 Company snapshot

      • 8.6.3 Operating business segments

      • 8.6.4 Product portfolio

      • 8.6.5 Business performance

      • 8.6.6 Key strategic moves and developments

    • 8.7 Pediatric Advanced Therapy

      • 8.7.1 Company overview

      • 8.7.2 Company snapshot

      • 8.7.3 Operating business segments

      • 8.7.4 Product portfolio

      • 8.7.5 Business performance

      • 8.7.6 Key strategic moves and developments

    • 8.8 Chatham Speech and Myo

      • 8.8.1 Company overview

      • 8.8.2 Company snapshot

      • 8.8.3 Operating business segments

      • 8.8.4 Product portfolio

      • 8.8.5 Business performance

      • 8.8.6 Key strategic moves and developments

    • 8.9 Movement Masters Physical Therapy

      • 8.9.1 Company overview

      • 8.9.2 Company snapshot

      • 8.9.3 Operating business segments

      • 8.9.4 Product portfolio

      • 8.9.5 Business performance

      • 8.9.6 Key strategic moves and developments

    • 8.10 Rio Children's Hospital

      • 8.10.1 Company overview

      • 8.10.2 Company snapshot

      • 8.10.3 Operating business segments

      • 8.10.4 Product portfolio

      • 8.10.5 Business performance

      • 8.10.6 Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 2. CRI-DU-CHAT SYNDROME TREATMENT MARKET FOR PHYSIOTHERAPY, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 3. CRI-DU-CHAT SYNDROME TREATMENT MARKET FOR PHYSIOTHERAPY, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 4. CRI-DU-CHAT SYNDROME TREATMENT MARKET FOR SPEECH THERAPY, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 5. CRI-DU-CHAT SYNDROME TREATMENT MARKET FOR SPEECH THERAPY, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 6. CRI-DU-CHAT SYNDROME TREATMENT MARKET FOR OCCUPATIONAL THERAPY, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 7. CRI-DU-CHAT SYNDROME TREATMENT MARKET FOR OCCUPATIONAL THERAPY, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 8. GLOBAL CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 9. CRI-DU-CHAT SYNDROME TREATMENT MARKET FOR HOSPITALS AND SPECIALTY CLINICS, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 10. CRI-DU-CHAT SYNDROME TREATMENT MARKET FOR HOSPITALS AND SPECIALTY CLINICS, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 11. CRI-DU-CHAT SYNDROME TREATMENT MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 12. CRI-DU-CHAT SYNDROME TREATMENT MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 13. CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 14. NORTH AMERICA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 15. NORTH AMERICA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 16. NORTH AMERICA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 17. U.S. CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 18. U.S. CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 19. CANADA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 20. CANADA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 21. MEXICO CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 22. MEXICO CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 23. EUROPE CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 24. EUROPE CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 25. EUROPE CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 26. GERMANY CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 27. GERMANY CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 28. FRANCE CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 29. FRANCE CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 30. UK CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 31. UK CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 32. ITALY CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 33. ITALY CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 34. SPAIN CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 35. SPAIN CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 36. REST OF EUROPE CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 37. REST OF EUROPE CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 38. ASIA-PACIFIC CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 39. ASIA-PACIFIC CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 40. ASIA-PACIFIC CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 41. JAPAN CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 42. JAPAN CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 43. CHINA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 44. CHINA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 45. INDIA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 46. INDIA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 47. AUSTRALIA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 48. AUSTRALIA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 49. SOUTH KOREA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 50. SOUTH KOREA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 51. REST OF ASIA-PACIFIC CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 52. REST OF ASIA-PACIFIC CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 53. LAMEA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 54. LAMEA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 55. LAMEA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 56. BRAZIL CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 57. BRAZIL CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 58. SAUDI ARABIA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 59. SAUDI ARABIA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 60. SOUTH AFRICA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 61. SOUTH AFRICA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 62. REST OF LAMEA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 63. REST OF LAMEA CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
    TABLE 64.HOPPERS PHYSIO: COMPANY SNAPSHOT
    TABLE 65.HOPPERS PHYSIO: OPERATING SEGMENTS
    TABLE 66.HOPPERS PHYSIO: PRODUCT PORTFOLIO
    TABLE 67.HOPPERS PHYSIO: NET SALES
    TABLE 68.HOPPERS PHYSIO: KEY STRATERGIES
    TABLE 69.JEEVAM THERAPY: COMPANY SNAPSHOT
    TABLE 70.JEEVAM THERAPY: OPERATING SEGMENTS
    TABLE 71.JEEVAM THERAPY: PRODUCT PORTFOLIO
    TABLE 72.JEEVAM THERAPY: NET SALES
    TABLE 73.JEEVAM THERAPY: KEY STRATERGIES
    TABLE 74.PHYSIOCOMESTOYOU: COMPANY SNAPSHOT
    TABLE 75.PHYSIOCOMESTOYOU: OPERATING SEGMENTS
    TABLE 76.PHYSIOCOMESTOYOU: PRODUCT PORTFOLIO
    TABLE 77.PHYSIOCOMESTOYOU: NET SALES
    TABLE 78.PHYSIOCOMESTOYOU: KEY STRATERGIES
    TABLE 79.EURO-THERAPIES: COMPANY SNAPSHOT
    TABLE 80.EURO-THERAPIES: OPERATING SEGMENTS
    TABLE 81.EURO-THERAPIES: PRODUCT PORTFOLIO
    TABLE 82.EURO-THERAPIES: NET SALES
    TABLE 83.EURO-THERAPIES: KEY STRATERGIES
    TABLE 84.INSTITUTE FOR CHILD DEVELOPMENT: COMPANY SNAPSHOT
    TABLE 85.INSTITUTE FOR CHILD DEVELOPMENT: OPERATING SEGMENTS
    TABLE 86.INSTITUTE FOR CHILD DEVELOPMENT: PRODUCT PORTFOLIO
    TABLE 87.INSTITUTE FOR CHILD DEVELOPMENT: NET SALES
    TABLE 88.INSTITUTE FOR CHILD DEVELOPMENT: KEY STRATERGIES
    TABLE 89.BLOSSOMS PHYSIOTHERAPY: COMPANY SNAPSHOT
    TABLE 90.BLOSSOMS PHYSIOTHERAPY: OPERATING SEGMENTS
    TABLE 91.BLOSSOMS PHYSIOTHERAPY: PRODUCT PORTFOLIO
    TABLE 92.BLOSSOMS PHYSIOTHERAPY: NET SALES
    TABLE 93.BLOSSOMS PHYSIOTHERAPY: KEY STRATERGIES
    TABLE 94.PEDIATRIC ADVANCED THERAPY: COMPANY SNAPSHOT
    TABLE 95.PEDIATRIC ADVANCED THERAPY: OPERATING SEGMENTS
    TABLE 96.PEDIATRIC ADVANCED THERAPY: PRODUCT PORTFOLIO
    TABLE 97.PEDIATRIC ADVANCED THERAPY: NET SALES
    TABLE 98.PEDIATRIC ADVANCED THERAPY: KEY STRATERGIES
    TABLE 99.CHATHAM SPEECH AND MYO: COMPANY SNAPSHOT
    TABLE 100.CHATHAM SPEECH AND MYO: OPERATING SEGMENTS
    TABLE 101.CHATHAM SPEECH AND MYO: PRODUCT PORTFOLIO
    TABLE 102.CHATHAM SPEECH AND MYO: NET SALES
    TABLE 103.CHATHAM SPEECH AND MYO: KEY STRATERGIES
    TABLE 104.MOVEMENT MASTERS PHYSICAL THERAPY: COMPANY SNAPSHOT
    TABLE 105.MOVEMENT MASTERS PHYSICAL THERAPY: OPERATING SEGMENTS
    TABLE 106.MOVEMENT MASTERS PHYSICAL THERAPY: PRODUCT PORTFOLIO
    TABLE 107.MOVEMENT MASTERS PHYSICAL THERAPY: NET SALES
    TABLE 108.MOVEMENT MASTERS PHYSICAL THERAPY: KEY STRATERGIES
    TABLE 109.RIO CHILDREN'S HOSPITAL: COMPANY SNAPSHOT
    TABLE 110.RIO CHILDREN'S HOSPITAL: OPERATING SEGMENTS
    TABLE 111.RIO CHILDREN'S HOSPITAL: PRODUCT PORTFOLIO
    TABLE 112.RIO CHILDREN'S HOSPITAL: NET SALES
    TABLE 113.RIO CHILDREN'S HOSPITAL: KEY STRATERGIES

  • LIST OF FIGURES

  • FIGURE 1.CRI-DU-CHAT SYNDROME TREATMENT MARKET SEGMENTATION
    FIGURE 2.CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031
    FIGURE 3.CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.CRI-DU-CHAT SYNDROME TREATMENT MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 12.CRI-DU-CHAT SYNDROME TREATMENT MARKET,BY TREATMENT,2021(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF PHYSIOTHERAPY CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF SPEECH THERAPY CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031(%)
    FIGURE 15.COMPARATIVE SHARE ANALYSIS OF OCCUPATIONAL THERAPY CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031(%)
    FIGURE 16.CRI-DU-CHAT SYNDROME TREATMENT MARKET,BY END USER,2021(%)
    FIGURE 17.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND SPECIALTY CLINICS CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031(%)
    FIGURE 18.COMPARATIVE SHARE ANALYSIS OF OTHERS CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031(%)
    FIGURE 19.CRI-DU-CHAT SYNDROME TREATMENT MARKET BY REGION,2021
    FIGURE 20.U.S. CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031($THOUSAND)
    FIGURE 21.CANADA CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031($THOUSAND)
    FIGURE 22.MEXICO CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031($THOUSAND)
    FIGURE 23.GERMANY CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031($THOUSAND)
    FIGURE 24.FRANCE CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031($THOUSAND)
    FIGURE 25.UK CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031($THOUSAND)
    FIGURE 26.ITALY CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031($THOUSAND)
    FIGURE 27.SPAIN CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031($THOUSAND)
    FIGURE 28.REST OF EUROPE CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031($THOUSAND)
    FIGURE 29.JAPAN CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031($THOUSAND)
    FIGURE 30.CHINA CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031($THOUSAND)
    FIGURE 31.INDIA CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031($THOUSAND)
    FIGURE 32.AUSTRALIA CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031($THOUSAND)
    FIGURE 33.SOUTH KOREA CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031($THOUSAND)
    FIGURE 34.REST OF ASIA-PACIFIC CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031($THOUSAND)
    FIGURE 35.BRAZIL CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031($THOUSAND)
    FIGURE 36.SAUDI ARABIA CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031($THOUSAND)
    FIGURE 37.SOUTH AFRICA CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031($THOUSAND)
    FIGURE 38.REST OF LAMEA CRI-DU-CHAT SYNDROME TREATMENT MARKET,2021-2031($THOUSAND)
    FIGURE 39. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 42.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 43.COMPETITIVE DASHBOARD
    FIGURE 44.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 45.HOPPERS PHYSIO.: NET SALES ($THOUSAND)
    FIGURE 46.JEEVAM THERAPY.: NET SALES ($THOUSAND)
    FIGURE 47.PHYSIOCOMESTOYOU.: NET SALES ($THOUSAND)
    FIGURE 48.EURO-THERAPIES.: NET SALES ($THOUSAND)
    FIGURE 49.INSTITUTE FOR CHILD DEVELOPMENT.: NET SALES ($THOUSAND)
    FIGURE 50.BLOSSOMS PHYSIOTHERAPY.: NET SALES ($THOUSAND)
    FIGURE 51.PEDIATRIC ADVANCED THERAPY.: NET SALES ($THOUSAND)
    FIGURE 52.CHATHAM SPEECH AND MYO.: NET SALES ($THOUSAND)
    FIGURE 53.MOVEMENT MASTERS PHYSICAL THERAPY.: NET SALES ($THOUSAND)
    FIGURE 54.RIO CHILDREN'S HOSPITAL.: NET SALES ($THOUSAND)

 
 

This section provides opinions of top level CXOs in the global cri-du-chat syndrome treatment market. According to the insights of CXOs, leading companies in the market, development of advanced and reliable physiotherapy, speech therapy and occupational therapy has led to extensive number of applications of these therapies. Increase in prevalence of cri-du-chat syndrome and better healthcare services is also expected to propel the growth of the cri-du-chat syndrome treatment market.
Asia-Pacific and LAMEA are anticipated to present significant development opportunities to leading market players during the forecast period.. According to the perspectives of CXOs of leading organization in the market, significant advancements in the physiotherapy with increase in clinically backed research, growing investments, funds, and grants, increasing incidence of cri-du-chat syndrome, entry of new player is projected to drive the market growth. 
 

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The increase in prevalence of disease and surge in awareness regarding physiotherapy are the upcoming trends of Cri-du-chat syndrome treatment market.

A. North America is the largest regional market for Cri-du-chat syndrome treatment market.

A. Physiotherapy is the leading treatment of Cri-du-chat syndrome treatment market.

A. Hoppers Physio, Jeevam Therapy, Physiocomestoyou, EURO-THERAPIES, Institute for Child Development, Blossoms Physiotherapy, Pediatric Advanced Therapy, Chatham Speech and Myo, Movement Masters Physical Therapy, and Rio Children's Hospital are the top companies to hold the market share in cri-du-chat syndrome treatment market.

A. 2021 is the base year of cri-du-chat syndrome treatment market.

A. The global cri-du-chat syndrome treatment market was valued at $1,332.46 thousand in 2021, and is estimated to reach $1,918.21 thousand by 2031, growing at a CAGR of 3.7% from 2022 to 2031.

A. 2022 to 2031 is the forecast period of cri-du-chat syndrome treatment market.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Cri-du-chat Syndrome Treatment Market

Start reading instantly.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Oct 2023 - Oct 2024)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2023 - Oct 2024)
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2023 - Oct 2024)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2023 - Oct 2024)

  • Enterprise
    License/PDF

  • $9,600
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2023 - Oct 2024)

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers